Cyclica teams with academics to investigate COVID-19 treatment

This post was adapted from its original source on Outsourcing Pharma and can be viewed here.

The drug-discovery firm has partnered with several academic institutions to explore a Novartis lung-cancer treatment’s potential in treating COVID-19.

Read the full article on Outsourcing Pharma →